AstraZeneca PLC (NASDAQ: AZN) is recognized as one of the Top 10 Safest Dividend Stocks in the UK, offering a resilient and predictable dividend structure. The company is well-positioned to handle upcoming patent expirations with a robust pipeline of drugs, including promising treatments like AZD5004 and AZD6234 in weight management.

AstraZeneca PLC (NASDAQ: AZN) has announced plans to invest $50 billion in the US by 2030, creating thousands of jobs. This includes the development of a new manufacturing site focusing on weight management and metabolic treatments. The company has a solid dividend track record, paying uninterrupted dividends for 32 years, with an interim dividend of $1.03 per share and a yield of 2.13%.

While AstraZeneca (AZN) is a strong dividend payer, some believe that certain AI stocks offer greater upside potential with less risk. For those seeking undervalued AI stocks, a free report on the best short-term AI stock is available. The company’s commitment to innovation and growth in drug development makes it a key player in the pharmaceutical industry.

Read more at Yahoo Finance: Resilient, Predictable, and Built on Innovation